Literature DB >> 8585486

MR anatomy of the substantia innominata and findings in Alzheimer disease: a preliminary report.

M Sasaki1, S Ehara, Y Tamakawa, S Takahashi, H Tohgi, A Sakai, T Mita.   

Abstract

PURPOSE: To demonstrate normal MR anatomy of the substantia innominata and its changes in Alzheimer disease on MR imaging.
METHODS: Using a 1.5-T superconductive MR unit, thickness of the substantia innominata was measured on coronal thin-section images obtained in 22 patients with Alzheimer disease and 14 age-matched control subjects. Comparison of these images with postmortem specimens of human brain was also performed.
RESULTS: On T2-weighted images through the anterior commissure, the substantia innominata was clearly identified between the globus pallidus and the anterior perforated substance. In Alzheimer disease, thinning of the substantia innominata was more frequently observed than in the age-matched controls.
CONCLUSION: Thin-section T2-weighted coronal MR images can demonstrate shrinkage of the substantia innominata, a finding that may aid in the diagnosis of Alzheimer disease.

Entities:  

Mesh:

Year:  1995        PMID: 8585486      PMCID: PMC8337225     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  13 in total

Review 1.  Mild cognitive impairment: pathology and mechanisms.

Authors:  Elliott J Mufson; Lester Binder; Scott E Counts; Steven T DeKosky; Leyla de Toledo-Morrell; Stephen D Ginsberg; Milos D Ikonomovic; Sylvia E Perez; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

2.  Differences in MR features of the substantia innominata between dementia with Lewy bodies and Alzheimer's disease.

Authors:  Haruo Hanyu; Yuriko Tanaka; Soichiro Shimizu; Hirofumi Sakurai; Toshiko Iwamoto; Kimihiko Abe
Journal:  J Neurol       Date:  2005-03-18       Impact factor: 4.849

3.  Assessment of the Virchow-Robin Spaces in Alzheimer disease, mild cognitive impairment, and normal aging, using high-field MR imaging.

Authors:  W Chen; X Song; Y Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-14       Impact factor: 3.825

4.  Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain.

Authors:  Laszlo Zaborszky; L Hoemke; H Mohlberg; A Schleicher; K Amunts; K Zilles
Journal:  Neuroimage       Date:  2008-06-07       Impact factor: 6.556

5.  MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia.

Authors:  Haruo Hanyu; Tetsuichi Asano; Hirofumi Sakurai; Yuriko Tanaka; Masaru Takasaki; Kimihiko Abe
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

6.  Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study.

Authors:  Ingo Kilimann; Michel Grothe; Helmut Heinsen; Eduardo Joaquim Lopez Alho; Lea Grinberg; Edson Amaro; Gláucia Aparecida Bento Dos Santos; Rafael Emídio da Silva; Alex J Mitchell; Giovanni B Frisoni; Arun L W Bokde; Andreas Fellgiebel; Massimo Filippi; Harald Hampel; Stefan Klöppel; Stefan J Teipel
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 7.  Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.

Authors:  Krista L Lanctôt; Nathan Herrmann; Maysoon M LouLou
Journal:  J Psychiatry Neurosci       Date:  2003-01       Impact factor: 6.186

8.  MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD.

Authors:  S George; E J Mufson; S Leurgans; R C Shah; C Ferrari; L deToledo-Morrell
Journal:  Neurobiol Aging       Date:  2009-12-14       Impact factor: 4.673

9.  Substantia innominata: MR findings in Parkinson's disease.

Authors:  Hirobumi Oikawa; Makoto Sasaki; Shigeru Ehara; Takashi Abe
Journal:  Neuroradiology       Date:  2004-10       Impact factor: 2.804

10.  Atrophy measurement of the anterior commissure and substantia innominata with 3T high-resolution MR imaging: does the measurement differ for patients with frontotemporal lobar degeneration and Alzheimer disease and for healthy subjects?

Authors:  W-J Moon; H-J Kim; H G Roh; S-H Han
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-24       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.